跳至主要内容
临床试验/NCT04153435
NCT04153435已完成2 期

Calcium for Out-of-Hospital Cardiac Arrest - A Randomized, Double-Blind, Placebo-Controlled Trial

Lars Wiuff Andersen1 个研究点 分布在 1 个国家目标入组 397 人开始时间: 2020年1月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
397
试验地点
1
主要终点
Number of Participants With Sustained Return of Spontaneous Circulation

研究概览

简要总结

This is an investigator-initiated, multicenter, randomized, placebo-controlled, parallel group, double-blind, superiority trial of calcium during adult out-of-hospital cardiac arrest. 430 adult patients with out-of-hospital cardiac arrest receiving at least one dose of adrenaline will be enrolled. The primary outcome is sustained return of spontaneous circulation and key secondary outcomes include survival at 30 days and survival at 30 days with a favorable neurological outcome.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Out-of-hospital cardiac arrest
  • Age ≥ 18 years
  • Received at least one dose of adrenaline

排除标准

  • Traumatic cardiac arrest - including drowning and external asphyxia (e.g., hanging, strangulation, or foreign object airway obstruction)
  • Known or strongly suspected pregnancy
  • Prior enrollment in the trial
  • Received adrenaline during cardiac arrest before arrival of prehospital personnel with the study drug
  • Clinical indication for calcium administration during the cardiac arrest

研究组 & 干预措施

Calcium

Experimental

The intervention will consist of 5 mmol (10 mL ampoule) of calcium chloride (CaCl2) administered intravenously or intraosseously immediately after the first dose of adrenaline and again after the second dose of adrenaline.

干预措施: Calcium Chloride (Drug)

Placebo

Placebo Comparator

The placebo will consist of 10 mL of 9 mg/mL sodium chloride (NaCl, "normal saline") administered intravenously or intraosseously immediately after the first dose of adrenaline and again after the second dose of adrenaline.

干预措施: Sodium chloride 0.9% (Drug)

结局指标

主要结局

Number of Participants With Sustained Return of Spontaneous Circulation

时间窗: Before or after hospital arrival (up to 2 hours after the cardiac arrest)

Palpable pulses or other signs of circulation without a need for chest compressions lasting at least 20 minutes.

次要结局

  • Number of Participants With 30-day Survival(30 days after the cardiac arrest)
  • Number of Participants With 30-day Favorable Neurological Outcome(30 days after the cardiac arrest)

研究者

发起方
Lars Wiuff Andersen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Lars Wiuff Andersen

Associate Professor

Aarhus University Hospital

研究点 (1)

Loading locations...

相似试验